# GNA11

Source: https://onco.cc/targets/gna11/  
OnCo record `gna11` (Target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

GNA11 (Guanine nucleotide-binding protein subunit alpha-11) is a gene that drives cell growth when it is altered. The public catalogues list it as a drug target, an oncogene driver and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Skin cancer, Lung cancer, Melanoma and 1 more.

## Summary

Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signalling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signalling by an activated GPCR promotes GDP release and GTP binding.

CIViC holds 9 clinical evidence items and 0 assertions across 5 variants, naming Trametinib, Mirdametinib, Selumetinib and Cabozantinib and others. Open Targets scores its association with cancer at 0.72 (direct and indirect evidence; datatypes affected pathway 0.83, literature 0.90, genetic association 0.00, somatic mutation 0.90, animal model 0.63). IntOGen calls it a driver in 2 cohorts (2 activating, 0 loss-of-function), covering Melanoma, Uveal Melanoma. In OnCo, 1 product record names it (Darovasertib).

## Fields

- Kind: Target
- Last checked: 2026-09-23
- Also known as: G protein subunit alpha 11; Guanine nucleotide-binding protein subunit alpha-11; FBH2; FHH2; HHC2
- Tags: cancer-genes-wave
- Symbol: GNA11
- Class: oncogene
- Biology: Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signalling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signalling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins. Signalling is mediated via phospholipase C-beta-dependent inositol lipid hydrolysis for signal propagation: activates phospholipase C-beta: following GPCR activation, GNA11 activates PLC-beta (PLCB1, PLCB2, PLCB3 or PLCB4), leading to production of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Location: Cell membrane; Cytoplasm (UniProt). Locus 19p13.3 (HGNC).
- Where found: Skin cancer: Open Targets association 0.62 with skin cancer (MONDO_0002898); Lung cancer: Open Targets association 0.51 with lung cancer (MONDO_0008903); Melanoma: Open Targets association 0.71 with melanoma (MONDO_0005105); IntOGen driver in 1 cohort (MEL); Uveal melanoma: Open Targets association 0.63 with ocular melanoma (MONDO_0006325); CIViC evidence names this disease

## Notes

- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: CIViC lists 6 therapies; IntOGen calls it an activating (Act) driver in 2 cohorts; CIViC holds 9 clinical evidence items on its variants. Evidence tier "clinical-evidence" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
- Diseases the sources name that have no OnCo cancer page yet, so they are not linked: Congenital Hemangioma.

## Sources

- HGNC HGNC:4379: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4379
- UniProt P29992: https://www.uniprot.org/uniprotkb/P29992/entry
- NCBI Gene 2767: https://www.ncbi.nlm.nih.gov/gene/2767
- Ensembl ENSG00000088256: https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000088256

## Connected records

- collections: [CIViC](https://onco.cc/collections/civic/), [IntOGen](https://onco.cc/collections/intogen/), [Open Targets Platform](https://onco.cc/collections/open-targets/)
- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/), [Melanoma](https://onco.cc/cancers/melanoma/), [Skin cancer (all types)](https://onco.cc/cancers/skin-cancer/), [Uveal melanoma](https://onco.cc/cancers/uveal-melanoma/)
- drugs: [Darovasertib](https://onco.cc/drugs/darovasertib/)

---
JSON: https://onco.cc/api/v1/entities/gna11.json